Everest Organics Ltd vs Parmax Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Everest Organics Ltd is ₹ 276 as of 04 May 11:16 . The P/E Ratio of Everest Organics Ltd changed from 13.4 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Parmax Pharma Ltd changed from 21 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Everest Organics Ltd changed from ₹ 183.96 crore on March 2021 to ₹ 244.71 crore on March 2025 . This represents a CAGR of 5.87% over 5 yearsThe Market Cap of Parmax Pharma Ltd changed from ₹ 13.28 crore on March 2021 to ₹ 15.8 crore on March 2025 . This represents a CAGR of 3.54% over 5 years The revenue of Everest Organics Ltd for the Dec '25 is ₹ 42.84 crore as compare to the Sep '25 revenue of ₹ 51.29 crore. This represent the decline of -16.47% The revenue of Parmax Pharma Ltd for the Dec '25 is ₹ 4.33 crore as compare to the Sep '25 revenue of ₹ 2.54 crore. This represent the growth of 70.47% The ebitda of Everest Organics Ltd for the Dec '25 is ₹ 3.79 crore as compare to the Sep '25 ebitda of ₹ 5.42 crore. This represent the decline of -30.07% The ebitda of Parmax Pharma Ltd for the Dec '25 is ₹ -0.19 crore as compare to the Sep '25 ebitda of ₹ -1.58 crore. This represent the decline of -87.97% The net profit of Everest Organics Ltd changed from ₹ -6.09 crore to ₹ 0.36 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Parmax Pharma Ltd changed from ₹ 0.01 crore to ₹ -0.73 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Everest Organics Ltd changed from 8.75 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Parmax Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Everest Organics Ltd

Everest Organics Limited was incorporated at Hyderabad in February, 1993.
It was promoted by S K Srihari Raju and S K. Chittiramabhadra Raju.
The Company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries.
The Company commenced its commercial operations in the year 1993.
It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations.

About Parmax Pharma Ltd

Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
The Company then discontinued their business activities for few years due to various reasons.
Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

FAQs for the comparison of Everest Organics Ltd and Parmax Pharma Ltd

Which company has a larger market capitalization, Everest Organics Ltd or Parmax Pharma Ltd?

Market cap of Everest Organics Ltd is 264 Cr while Market cap of Parmax Pharma Ltd is 11 Cr

What are the key factors driving the stock performance of Everest Organics Ltd and Parmax Pharma Ltd?

The stock performance of Everest Organics Ltd and Parmax Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Everest Organics Ltd and Parmax Pharma Ltd?

As of May 4, 2026, the Everest Organics Ltd stock price is INR ₹272.15. On the other hand, Parmax Pharma Ltd stock price is INR ₹30.02.

How do dividend payouts of Everest Organics Ltd and Parmax Pharma Ltd compare?

To compare the dividend payouts of Everest Organics Ltd and Parmax Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.